Store-brand phenylephrine products from Leiner will begin shipping in June to fill the gap on retail shelves left by pseudoephedrine, the private labeler announced April 22. The announcement follows Target's decision to place pseudoephedrine behind pharmacy counters. Phenylephrine is an active ingredient in Bayer's Alka-Seltzer Plus and compared to pseudoephedrine, "has fewer side effects and...does not interfere with sleep," Leiner claims. The firm's products will compete with Pfizer's Sudafed PE phenylephrine, launched in January, and other private-label offerings...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.
The reductions across medical product programs in the agency’s budget request include hundreds of positions funded by user fees, which may foreshadow its upcoming user fee restructuring strategy.
A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.